BSC'S SYNERGY MUST EXIT U.S. MARKET IN 1996 UNDER SETTLEMENT WITH ACS
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's Synergy rapid-exchange coronary angioplasty catheter will be removed from the U.S. market after Aug. 31, 1996 under the terms of a settlement with Lilly subsidiary Advanced Cardiovascular Systems, Inc. announced Nov. 10.